Analytical validation and clinical concordance of Diazyme free light chain assays on the Cobas® platform compared with Freelite™
Annales de Biologie Clinique · 2026-06 · 84 (3) · 245-252
DOI: 10.1684/abc.2026.2044 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Annales de Biologie Clinique, 2026-06. Verfasst von Wafa Masri und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine and Pathology, Grand Hôpital de l'Est Francilien, Meaux, France. Hauptthemen laut MEDLINE: Paraproteinemias, Immunoglobulin kappa-Chains, Immunoglobulin lambda-Chains, Immunoglobulin Light Chains.
Abstract (Originalsprache)
Serum free light chains (FLC) are key biomarkers for the diagnosis and monitoring of plasma cell dyscrasias. Current International Myeloma Working Group (IMWG) recommendations are based on Freelite™ assays. This study aimed to evaluate the analytical performance and clinical concordance of Diazyme κ and λ FLC assays on the Roche Cobas® platform in comparison with Freelite™. A total of 660 serum samples from patients with multiple myeloma, MGUS/smoldering myeloma, Waldenström macroglobulinemia, AL amyloidosis, and other gammopathies were analyzed. Precision, reference intervals, and method comparison were assessed according to CLSI EP05-A3 and EP09-A3 guidelines. Statistical analyses included Passing-Bablok regression, Bland-Altman analysis, Pearson correlation, and evaluation of clinical concordance. Within-run and total imprecision showed coefficients of variation ≤ 6%. Reference intervals for the κ/λ ratio were 0.22-2.25 in healthy individuals and 0.30-2.75 in patients with renal insufficiency. Method comparison demonstrated strong agreement with Freelite™ for κ (y = 0.95x + 0.34, R² = 0.96), λ (y = 0.90x + 4.1, R² = 0.91), and κ/λ ratio (r = 0.92). Overall clinical concordance was 96%, with discrepancies mainly observed near decision thresholds. Diazyme κ and λ FLC assays on the Cobas® platform show excellent analytical performance and high clinical concordance with Freelite™, supporting their use in routine laboratory practice, with applicability to IMWG-based interpretation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Laboratory Medicine and Pathology, Grand Hôpital de l'Est Francilien, Meaux, France.
- Department of Clinical Hematology, Grand Hôpital de l'Est Francilien, Meaux, France.
Zitieren
APA
Masri, W., Abarah, W., Taileb, M., Cung, A., & Bendaoud, M. (2026). Analytical validation and clinical concordance of Diazyme free light chain assays on the Cobas® platform compared with Freelite™. Annales de Biologie Clinique, 84(3), 245-252. https://doi.org/10.1684/abc.2026.2044
Vancouver
Masri W, Abarah W, Taileb M, Cung A, Bendaoud M. Analytical validation and clinical concordance of Diazyme free light chain assays on the Cobas® platform compared with Freelite™. Annales de Biologie Clinique. 2026;84(3):245-252. doi:10.1684/abc.2026.2044
BibTeX
@article{Masri2026,
author = {Masri, Wafa and Abarah, Wajed and Taileb, Mustapha and Cung, Anh and Bendaoud, Mourad},
title = {Analytical validation and clinical concordance of Diazyme free light chain assays on the Cobas® platform compared with Freelite™},
journal = {Annales de Biologie Clinique},
year = {2026},
volume = {84},
number = {3},
pages = {245--252},
doi = {10.1684/abc.2026.2044}
}
EUVIMED